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EXECUTIVE SUMMARY 
The first step in the toxicity mechanism involves the interaction between the chemical and one or more 
macromolecular targets which may consists on genetic material, enzymes/proteins, transport 
molecules, receptors, etc. Therefore, to progress in this direction, it is necessary to develop approaches 
able to link adverse effects (or measurable physiological changes) at high level to initiating events at 
molecular level through a complete pathway of biochemical reactions. Chemical toxicity in most of the 
cases has a metabolic component and metabolic pathways are the most studied biochemical reactions. 
For these reasons we have started to analyze modelling approaches for studying toxicity at molecular 
level using the metabolism as a case study. In addition, to facilitate the study, we have focused on cell-
based assays –in this case HepG2 cell lines.  
Two approaches have been investigated. The first consists on the analysis of metabolic fluxes in 
HepG2 under different toxicants concentrations using complex network analysis tools. This is 
important when a correlation between dose-response curves and metabolomic data has to be 
established. The second approach is based on the implementation and application of a simplified 
dynamic model for the HepG2 metabolism. Both approaches are complementary, in the first case only 
metabolic fluxes are necessary and therefore a more detailed description of HepG2 metabolic network 
can be developed; whereas the second approach requires not only the specification of the biochemical 
reactions, but also their kinetic parameters and, therefore, at the moment, the data necessary to 
describe the HepG2 metabolism with the same level of detail is not available. The results suggest that a 
combined approach, starting from metabolic fluxes and then solving the kinetic equations as our 
experimental data and knowledge of metabolic pathways increases is the most promising avenue to 
develop a quantitative approach of toxicity at molecular level. In addition, there is the necessity to link 
the molecular level approach with the cell growth and mortality with an intermediate level that 
translates metabolism changes into measurable parameters in cell-based assays for the experimental 
validation. 
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1. INTRODUCTION 
Systems Toxicology integrates the methodologies of conventional toxicology, of high throughput 
molecular genomics, proteomics, metabonomics with bioinfomatics to analyse and predict the effects 
of environmental stressors or toxicants from chemical exposure to adverse effects. The final objective 
of Systems Toxicology is to be able to describe the response of a functioning organism to toxicants at 
all different levels of biological organization and complexity (NRC, 2007). 
The basic idea is to combine the information from several sources to gain a deeper understanding on 
the mechanisms of toxic action and to develop approaches allowing a more sensitive and earlier 
detection of adverse effects in toxicity studies. This constitutes a big challenge since it requires to 
study interactions between genes, proteins and metabolites and to integrate the results from different 
theoretical (EPA, 2003; Kitano 2002a,b) and experimental set-ups. However, a better understanding of 
the molecular mechanisms of toxicity is necessary to improve the extrapolation between experimental 
results, from low dose to high dose, from short term to chronic exposure, etc; therefore, reducing the 
animal testing as well as the dose levels needed for toxicity elucidation. 
The first step in the toxicity mechanism normally involves the interaction between the chemical and 
one or more macromolecular targets which may consists on genetic material, enzymes/proteins, 
transport molecules, receptors, etc. The general view is that the differences between chemicals acting 
with the same mode of action depend on the differences of interaction with the targets (Rabinowitz et 
al. 2008). However, to progress beyond the mechanism or mode of action concept, it is necessary to 
develop approaches able to link adverse effects to initiating events through a complete pathway of 
biochemical and physiological changes, i.e. from receptor activation, to molecular discrete events, to 
cellular effects, to target organ responses, to apical end points, to physiological responses of the 
organism. This detailed knowledge would facilitate the use of models to treat certain chemicals as a 
family rather than individuals as well as to understand and predict minimal dose (Thresholds of 
Toxicological Concern –TTC- paradigm, see Kroes et al. 2005). 
In general terms, metabolism can be defined as the overall set of chemical reactions that occur in a 
living organism and the chemical reactions may be separated in two categories: catabolic –breakdown 
and produce energy- and anabolic –use energy to build up essential components-. Chemical toxicity in 
most of the cases has a metabolic component (Patterson and Idle, 2009), which in most cases are 
detoxification products (the conversion of the toxic compound in more soluble and easy to excrete). 
Therefore one way to gain insight into the toxicity mechanisms is to characterize the differences in 
metabolism when biological matrices are exposed to a certain substance that exerts a toxic effect. 
The qualitative and quantitative study of the metabolome is the subject of metabolomics where 
experimental techniques such as NMR (Nuclear Magnetic Resonance) and LC-MS (Liquid 
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chromatography-mass spectrometry) are employed in combination with advanced statistical and data 
modelling approaches (Patterson and Idle, 2009). A complement to this approach which may help to 
elucidate toxic effects at molecular level and formulate hypothesis that can be further validated using 
metabolomic approach consists on the development and implementation of mathematical models at 
different complexity levels. 
In this work, we have started to analyze several modelling approaches proposed for studying toxicity at 
molecular level using HepG2 cell lines. Two approaches have been investigated. The first approach 
consists on the analysis of metabolic fluxes in HepG2 (Metabolic Flux Balance, MFB) under different 
toxicants concentrations by complex network analysis tools. In addition, to the understanding of the 
results provided by MFB, it is important to check which parameters can be useful to characterize 
metabolomic data obtained from real experiments with the corresponding dose-response curves. The 
second approach is based on the development and application of a simplified dynamic model of 
metabolism. Whereas in the first case only metabolic fluxes are necessary and a quasi steady-state 
condition is assumed for internal metabolites, i.e. constant concentrations during time; the second 
approach requires the specification not only of the most important biochemical reactions –as in the 
first case-, but also their kinetic parameters, which, with our actual level of knowledge, implies 
considering lumped metabolic reactions, e.g. only one reaction for protein production. The preliminary 
results suggest that a combined approach starting from metabolic fluxes and then developing the 
metabolic kinetic equations, as our knowledge and experimental data increases, is the most promising 
avenue to develop a quantitative approach of toxicity at molecular level. The results obtained using 
complex network analysis suggest that it is also necessary to incorporate signalling and regulatory 
networks to have a more complete description of molecular pathways (Lee et al., 2008). In addition, 
there is the necessity to link the molecular level approach with the cell growth and mortality with an 
intermediate level that translates metabolism changes into measurable parameters in cell-based assays. 
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2. ANALYSIS AND MODELLING APPROACHES TO METABOLIC 
NETWORKS 
The analysis of complex metabolic networks has a static and a dynamic component. In the first case 
the metabolic network, see Fig. 1 as an example, is studied, using techniques developed from complex 
network analysis, to characterize its properties (Albert and Barabási, 2002; Newman, 2003). There 
have been a large number of studies on the statistical properties of such networks, which are usually 
considered as directed graphs in which the nodes correspond to metabolites and the connections 
between them correspond to reactions (edges), see Jeong et al., (2000); Fell and Wagner, (2000); 
Podani et al., (2001); Wagner and Fell, (2001); Stelling et al., (2002); Gulmerà and Nunes Amaral, 
(2005); amongst others. For example, Jeong et al. (2000) showed that metabolic networks were Small 
World networks; however, in their analysis they included connections through current metabolites, e.g. 
ATP, ADP, NADH, NAD+, etc. In a subsequent analysis Ma and Zeng (2003) showed that even after 
the removal of these connections, the networks still showed a power law distribution, but with longer 
pathways and diameters than previously calculated by Jeong et al. (2000). In addition, they identified 
several hub metabolites that were common in all organisms. 
 
 
Figure 1. Example of a reconstructed metabolic network. 
 
In the second case, i.e., the dynamic analysis, the objective is to obtain the time dependent changes of 
concentration of metabolites, proteins or other cellular components and reaction fluxes. An important 
consideration is the different time constants, the rate of change of a variable, that occur normally in 
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biochemical reaction networks that may led to a separation between slow and fast dynamics and, 
therefore, a reduction of the complexity of the problem. Dynamic mass balance models are typically 
formulated as a set of ordinary differential equations. This formulation has several important 
assumptions: the system is deterministic, i.e. the effects due to thermal noise or stochasticity due to 
few molecules present in the cell are not considered, cells are homogeneous with constant volume, and 
temperature is assumed constant. 
The compact form of the mass balance equations is: 
)(xvS
dt
dx
⋅=  (1) 
where S is the stoichiometic matrix, v is the vector of reaction fluxes and x is the vector of the 
concentration of metabolites. Figure 2 shows an example of a metabolic network, and the 
stoichiometric matrix. 
 
 
Figure 2.  Example of a metabolic network and the corresponding stoichiometic matrix S. The vi ‘s 
correspond to internal fluxes, whereas vsj and vpk are extracellular fluxes and refer to substrates and 
products, respectively. 
 
2.1. Metabolic networks characterization 
- Definitions and characterization of complex networks 
A graph G = (V, E) is defined with a node set V where n denotes the number of vertices, and a 
connection set E, where m denotes the number of connections. The topology of the graph can be 
presented by using the n×n adjacency matrix A, where aij ≠0 if (i, j) ∈ E and 0 otherwise. In the case of 
undirected graphs the adjacency matrix is symmetrical, aij = aji. It is possible also to assign certain 
numerical values, or weights, to the connections.  In this work, the fluxes between metabolites are the 
the weights that connect two metabolites, aij=vij. In addition, we have also used the square root of their 
inverses, aij=1/(vij)1/2, to mimic a distance matrix, i.e., higher the flux smaller the distance.  
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There are several measures to characterise complex networks. Here we briefly define those that we 
have used in this work to characterize the metabolic networks. 
- Local Measures: centrality measures 
There are a number of different measures of centrality. The degree centrality of a node in an 
undirected network is the number of ties a node has and does not take into account the connections 
weights. The betweenness centrality can be defined on a node or a connection, and it measures how 
many times a node or a connection occur on the shortest paths (geodesic) between other vertices in 
comparison with the total number of shortest paths. Node efficiency centrality is based on the idea that 
the most important vertices are most efficient in the connection with the other vertices where 
efficiency among two nodes is equal to inverse of the shortest path length (Latora and Marchiori, 
2001). 
- Global measures 
The distance between two vertices is the number of connections in a shortest path connecting them. 
The diameter of a network is the maximum length of all shortest paths between couples of vertices; 
whereas the characteristic path length is the average shortest path length. The largest component of a 
network is the largest subnetwork with all the nodes connected to each other directly or indirectly. In 
the case of social networks, the spread of information may be measured by the connectedness, R0, 
(Heffernan et al., 2005). The expected transmission for a node with centrality degree k and with a 
probability r to transfer, information will be r.(k-1), the node at the origin is excluded. The 
connectedness number is given by the weighted average over the vertices: 
k
kk
r
k
kk
rR
i i
i ii
−
=
−
=
∑
∑
2
0
)1(
  (2) 
If R0>1 then the transmission grows exponentially; if R0<1 the information spread will die out. The 
dependence by mean square degree means that a node with high degree has a higher probability to 
receive and/or to transmit information. The spread of information occurs if and only if Lr > , 
where )( 2 kkkL −= ; when 2k  is very large in comparison with k , L is small and then  r 
does not need to be large to spread information. Instead of checking if R0 >1, it is possible to check for 
kk 2=κ >2. κ  is called the connectivity parameter (Newman, 2008) and the value of 2 is a 
percolation threshold when the giant component (i.e., the subset of the original network which is 
connected and largest) disappears and the network becomes a set of small clusters.  
- Network robustness  
Different strategies have been employed in the literature to study the robustness of complex networks. 
In this work we have considered attacks based on the removal of vertices which can be divided into 
two categories: random and selective attacks (Holme et al., 2002). In the first case, the removal does 
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not require a new calculation of the network parameters, whereas in the second case the ranking can be 
recalculated for the new network after the node removal. In this work the selective attacks are 
performed based on node degree, efficiency, and betweenness centrality. This means that nodes with 
the highest degree or with the highest betweenness are first removed, after which the ranking is 
recalculated in order to select, in the next step, again the nodes with highest values of degree or 
betweenness (i.e., dynamic updating). The consequences of these attacks are measured by observing 
the changes of the global properties of networks i.e., size of the largest component (and the mean size 
of the others), diameter, characteristic length and connectivity. 
- Network conversion into time series 
The algorithms developed in Strozzi et al. (2009) to convert a time series into a network or vice versa 
have also been applied to the metabolic networks. The approach consider the adjacency matrix of a 
network as a recurrence plot, which consists on the computation of the distance between points in state 
space (Eckmann et al., 1987), of a time series and then tries to reconstruct a time series that would 
generate this recurrence plot. As showed by Hirata et al. (2008) these methods are able to reproduce 
the topological features of the original time series. However, as Xu et al. (2008) underlined, one 
drawback of this approach is that if we change the order in which the network nodes are visited, then 
the reconstructed time series can be different, even if the network is the same; but once we have 
established an order in which the nodes are visited, the reconstruction of the time series is unique.  
 
We have analysed the data with Pajek (Nooy et al., 2005) and Matlab®. Pajek has been used mostly 
for network visualization, whereas the network analyses have been performed with procedures written 
in Matlab using the functions of the MatlabBGL library (Gleich, 2006). MatlabBGL uses the Boost 
Graph Library to efficiently implement the graph algorithms on unweighted or weighted graphs and is 
designed to work with large sparse graphs with hundreds of thousands of nodes.  
2.2. Metabolic flux analysis 
Metabolic Flux Analysis (MFA) is a methodology developed for modelling metabolic networks by the 
determination of metabolic pathway fluxes (Stephanopoulos et al., 1998). In this methodology, 
intracellular fluxes are calculated by solving a linear system provided by a stoichiometric model 
(metabolic pathway map or stoichiometric matrix) and applying mass balances of the selected 
metabolites at steady-state conditions. As input, the linear system requires a set of measured rates, 
typically uptake and excretion extracellular fluxes of metabolites (substrates and products). The output 
is a steady state set of fluxes that solve the set of linear equations together with defined constraints 
and, to avoid the high number of possible solutions typical of an undetermined linear system, an 
objective function to maximize or minimize is also defined. 
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The pseudo-steady state assumption requires that the intracellular metabolites do not accumulate in the 
cell, which implies that Eq. (1) converts into: 
0S v⋅ =  (3) 
where S is the mxn stoichiometric matrix and v is the flux distribution vector. Assuming that only 
extracellular fluxes of substrates (s) and products (p) are measurable, we can write the extended system 
as: 
0
s s
p p
S
S v v
S v
   
   
⋅ =   
   
   
 with v ≥ 0 (4) 
where vs and vp are the measured uptake and excretion rates/fluxes. 
As explained above, normally the number of measurements is too small to make Eq. (3) determined. 
This means that the solution of Eq. (3) consists of a set of solutions Λ. Each solution of Eq. (3) can be 
written as a sum of nonnegative vectors, i.e. wi ≥ 0 "i, as: 
∑ ⋅=
i
ii wcv    (5) 
which can be written in compact notation as v=C.w with w≥ 0. C is a nxk matrix with k≥null(S)=n-m. 
This nonnegative combination is called the convex basis of the solution space (Rockafellar, 1970). The 
convex basis vectors are also called Elementary Flux Mode (EFM) and they define a pointed convex 
polyhedral cone in the k-dimensional nonnegative quadrant and are essentially a collection of various 
pathways alternatives for converting the external substrates into internal biomass and metabolic 
products . 
Combining Eqs. (3)-(5), we obtain 








=⋅







⋅
⋅
p
s
p
s
v
v
w
CS
CS
  (6) 
Usually k>s+p and Eq. (7) provides a set of solutions Λ. This solution set can, afterwards, be refined 
using additional knowledge, such as necessary products to feed the cell lines that cannot have zero 
fluxes as solution or biosynthesis products that we know are formed but not measured. 
In addition to the maximization of biomass yield, other goals have been defined such as the optimal 
metabolic regulation (Young et al., 2008) aiming at optimizing the distribution of uptake rates to 
maximize the carbon uptake by controlling the synthesis of enzymes that catalyze metabolic reactions. 
Furthermore, discussion on when MFA is admissible has also been the object of a considerable amount 
of work. For example, Song and Ramkrishna (2009) have proposed to examine the trajectories of 
extracellular measurements in flux space as a diagnostic tool to determine whether quasi-steady state 
assumption is valid. 
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A number of tools have been developed over the years to solve this constraint-based linear problem. A 
review of the different approaches and techniques may be found at Lewis et al. (2008) and software is 
freely available on Internet (Becker et al., 2007). 
2.3. Dynamic modelling of metabolic networks 
In this case, and taking into account the same assumptions that with MFA, a dynamic metabolic model 
for cell cultures can be described by the following set of ordinary differential equations: 
vS
dt
dx
c
s
s
⋅=
1
 (7) 
vS
dt
dx
c
p
p
⋅=
1
 (8) 
m
m xvS
dt
dx
⋅−⋅= µ  (9) 
µ=
dt
dc
c
1
 (10) 
where xs, xp and xm represent the extracellular (ns substrates and np products) and the intracellular 
components (nx), respectively; v is the vector of fluxes (nr), µ is the growth rate of biomass and c is the 
biomass weight defined per unit volume of the culture. The matrices Ss (nsxnr), Sp (npxnr) and S (nmxnr) 
represent the stoichiometic matrices relating v to the exchange and intracellular fluxes, respectively. 
The growth rate µ  can be obtained from the relation with the intracellular fluxes and the contribution 
of each flux normally available from literature (Stephanopoulos, et al., 1998) as: 
vhT ⋅=µ  (12) 
Conversely to MFA, in this case, it is necessary to write the kinetic equation that normally for enzyme 
catalyzed reactions can be written following the Michelis- Menten equation: 
maxV
xK
x
v i
m
i
m
i
m
i
+
=  (13) 
Where Kim is a function of two consecutive reactions: the binding of the ligand and the enzyme which 
is an equilibrium reaction (k1 and k-1) and the formation of the product (k2) to produce: 
i
ii
i
m k
kk
K
1
12 −+
=  (14) 
and Vmax in the maximal velocity which is directly proportional to the enzyme concentration and k2. 
The main problem with this approach, when compared to FBA (flux balance analysis), is the fact that 
one has to consider a high number of pathways for which a detailed reaction scheme and kinetic 
parameters are unknown and therefore lumped reactions are normally used. 
 
 
 9 
3. APPLICATION OF COMPLEX NETWORK ANALYSIS TO 
METABOLIC FLUXES OF HEPG2 WHEN EXPOSED TO SUBTOXIC 
CONCENTRATIONS 
In this Section we are going to study, using complex network analysis techniques, the effects of several 
toxicants on the metabolic fluxes of a HepG2 metabolic network. The metabolic fluxes were obtained 
by Niklas et al. (2009). They determined the effects on the cellular metabolism at subtoxic 
concentrations of several compounds: DMSO –to check the effects of this solvent-, amidarone, 
diclofenac and tacrine. To perform this calculation, they developed a metabolic network model (see 
figure 1) that comprised an HepG2 metabolic network with 62 fluxes: 23 extracellular fluxes (transport 
of compounds from outside the cell 21 substrates and 2 products), 34 intracellular reactions and 5 
lumped reactions for the synthesis of carbohydrates, DNA, RNA, lipids and proteins, respectively. For 
a detailed description of the metabolic reactions as well as the fluxes obtained assuming pseudo-steady 
state, the reader is referred to the Supplementary material of the original publication. Figure 2 shows 
the un-weighted network representation of the metabolic network considered by Niklas et al. (2009). 
 
 
Figure 1. Schematic representation of the metabolic fluxes considered by Niklas et al. (2009) for 
HepG2. 
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Figure 2. Un-weighted network representation of metabolic fluxes, ordered by distance from inside the 
cell, i.e., bottom: extracellular fluxes, top: Krebs’s cycle. Figure generated with the FoodWeb3D 
software (Wiliams, 2003). 
 
Our objective in this part of the work is to try to understand the relationship between toxic effects and 
the metabolic fluxes. We were expecting that, as the toxicant concentration increases, the vector of 
metabolic fluxes changes in some continuous form indicating that the functionalities of the metabolic 
network are decreasing. In this case, the main problem is how to find a way to convert the metabolic 
fluxes into a global measure of the performance of the network and then be able to compare this 
measure with a dose-response curve. In principle, one should expect that a correct metrics 
characterization of the changes in metabolic fluxes as a function of toxicant concentrations will 
provide an increasing or decreasing value, which is not the case of the results obtained calculating the 
simple Euclidean distance between the control (no compound) and the different treatments as it can be 
observed in Figure 3. In this case, the logical result would be that distance from the control should 
increase as a function of the dose.  
Since this simple distance calculation does not seem able to characterize the changes in the 
metabolism, we have applied several network characterization measures. A priori, it is not clear which 
measure will be the most appropriate to characterize these datasets. For this reason we have analyzed 
typical global static measures, but we have also analysed the use of network attack algorithms that test 
the robustness of the network and, finally, the conversion of the metabolic networks into time series 
(Strozzi et al., 2010) and the calculation of the distances once converted into them. 
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Figure 3. Sum of the Euclidean distances between fluxes differences with respect to the control 
experiment (without toxicant) as a function of compound concentrations. 
 
3.1. Global static measures 
We have calculated the global network measures defined in Section 2.1. There are some measures (e.g. 
network diameter which is based in the shortest path calculation) and algorithms (conversion to time 
series) that only work when the network is connected and undirected. Only in these cases, we have 
converted the adjacency matrix into a symmetric matrix. 
As an example, we have plotted the results obtained after measuring the network efficiency, mean 
clustering coefficient and mean betweeness centrality as a function of the doses of chemicals, for the 
flux’s matrices, Figures 4-6, and for the inverse of the fluxes, Figures 7-9. Even though in general 
terms the values follows what one should expect; for example, the efficiency of the network should 
decrease as the toxicant dose increases, there is no single global network measure that shows the same 
trend for all compounds as a function of the dose which could provide a metrics able to link fluxes 
with toxic effects.  
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Figure 4. Evolution of the efficiency of the fluxes networks as function of chemical dose 
 
Figure 5. Evolution of the mean clustering coefficient of the fluxes networks as function of chemical 
dose. 
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Figure 6. Evolution of the mean betweeness centrality coefficient of the fluxes networks as function of 
chemical dose. 
 
 
Figure 7. Evolution of the efficiency of the inverse of the fluxes networks as function of chemical 
dose. 
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Figure 8. Evolution of the mean clustering coefficient of the inverse of the fluxes networks as function 
of chemical dose. 
 
Figure 9. Evolution of the mean betweeness centrality coefficient of the inverse of the fluxes networks 
as function of chemical dose. 
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3.2. Network Robustness 
Since the global network measures do not provide a measure that links the toxic dose with the 
metabolic network functioning, we have tested measures based on attacking the network and 
measuring how the network is able to resists these attacks that are normally divided between random 
attacks, i.e. a node is removed randomly from the network, and selective attacks, i.e. the node that has 
the higher degree is removed and the network performance evaluated. Then the degree is re-calculated 
for the rest of the nodes and the process is repeated until the value of the measure reaches a certain 
threshold or until all nodes have been removed.  
Also in this case there is no a clear correlation between network robustness under random and selective 
attacks and toxic dose. As an example, we have plotted in Figures 10-13 the results for selective 
attacks based on the connectivity of the network for the four compounds, but similar results have been 
obtained for random or other types of selective attacks. 
 
 
Figure 10. Evolution of the connectivity of the DMSO networks as a function of the percentage of 
nodes attacked (0 % blue line, 0.0001 % green line, 0.001 % red line, 0.01% cyan line, 0.1 % magenta 
line, 0.5 % yellow line ,1 % black line, 2% discontinuous blue line, 3 % discontinuous green line). 
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Figure 11. Evolution of the connectivity of the Amidarone networks as a function of the percentage of 
nodes attacked (0 µM blue line, 0.5 µM green line, 1 µM red line, 3.16 µM cyan line, 10 µM magenta 
line). 
 
Figure 12. Evolution of the connectivity of the Diclofenac networks as a function of the percentage of 
nodes attacked  (0 µM blue line, 0.5 µM green line, 3.16 µM red line, 10 µM cyan line, 31.6 µM 
magenta line, 50 µM yellow line ,100 µM black line). 
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Figure 13. Evolution of the connectivity of the Tacrine networks as a function of the percentage of 
nodes attacked (0 µM blue line, 1 µM green line, 3.16 µM red line, 10 µM cyan line, 31.6 µM magenta 
line, 50 µM yellow line). 
 
3.3. Time series conversion 
The nine time series obtained for the case of the fluxes at several DMSO percentages are shown in Fig. 
14. Since the ordering of the metabolites and fluxes is the same in all matrices and the calculated 
fluxes does not change appreciably the generated time series are quite similar. However several 
differences can be observed around the point number 10 and between points 41-50. Point 10 
corresponds to OAA, whereas points 41-50 to several amino acids that change direction in the fluxes.  
In this case, we can also calculate a Euclidean distance between the control (no toxicant) and the 
different concentrations introduced. The results of this calculation are shown in Figure 15. As it can be 
observed also in this case, there is no clear trend that can correlate the increase in the concentration of 
the chemical with an increase/decrease of some property of the network. 
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Figure 14. Time series obtained from the metabolic flux matrices generated at nine different 
percentages of DMSO. 
 
Figure 15. Normalized sum of the Euclidean distances between the points in the generated time series 
with respect to the control (no compound) as a function of tested concentrations 
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4. DYNAMIC MODELLING OF HEPG2 
The dynamic model of HepG2 metabolism is based on the HEMET (HEpatocyte METabolism) model 
developed by De Maria et al. (2008). We describe briefly the equations here. However, for a detailed 
description the reader is referred to the original paper. 
4.1. Implementation of a dynamic model for HepG2 metabolism 
The model considers a schematic metabolic network represented by the following lumped biochemical 
reactions: 
a/ Glucose + ATP → Glucose-6-phosphate + ADP +H+ 
b/ Glucose-6-phosphate+2Pi+3ADP+2NAD+ → 2Pyruvate+3ATP+2NADH+H++2H2O 
c/ 3Glucose-6-phosphate + 6NADP+ + 5NAD+ + 5Pi+ 8ADP → 5Pyruvate + 3CO2 + 6NADPH + 
5NADH +8ATP+2H2O+8H+ 
d/ Glucose-6-phosphate+ATP+Glycogenn+2H2O → Glycogenn+1+ADP+2Pi 
e/ Pyruvate+ NAD+ + CoA → AcetylCoA+CO2+NADH 
f/ AcetylCoA + 3NAD++FAD+GDP+Pi+2H2O → 2 CO2 + 3NADH + FADH2 + GTP + 2H+ + CoA 
g/ α-aminoacid+NAD++H2O ↔ α-ketoacid+NH4++NADH+H+ 
h/ 8acetylCoA+7ATP+14NADPH+ 6H+ → palmitate+14NADP++8CoA+6H2O+7ADP+7Pi 
and 22 state variables reported in Table 1. 
 
Table 1. State variables in the model of HepG2 metabolism. 
State variable Symbol State variable Symbol 
Glucose glu Fumarate fumarate 
Glucose-6-phosphate glu6P L-malate Lmalate 
Pyruvate 1 pyruv1 Ossalacetate Ossalacetate 
Pyruvate 2 pyruv2 NADH NADH 
Glycogen nresidual ATP ATP 
Acetyl CoA AcetylCoA Aminoacids a.a. 
Citrate citrate Urea urea 
isocitrate isocitrate Acetyl CoA eq. A_CoA_eq 
αKetogl αKetogl Palmitate palmitate 
Succinyl CoA Succinyl CoA NADPH NADPH 
Succinate Succinate Albumin album 
 
Following De Maria et al. (2008), the mass balance equations for each state variable may be written as: 
1
[ ] [ ]d glu glu
dt
α= −  (15) 
2 2
[ 6 ] [ ] [ 6 ]d glu P glu glu P
dt
β α= −  (16) 
1
3 3 1
[ ] [ 6 ] [ ]d pyruv glu P pyruv
dt
β α= −  if [ATP]< σ1 (17) 
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2
4 3 2
[ ] [ 6 ] [ ]d pyruv glu P pyruv
dt
β α= −  if [ATP]> σ1 and [NADPH]< θ1 (18) 
[pyruv]=[pyruv1]+[pyruv2]  (19) 
4
( ) [ 6 ]residuald n d glu P
dt dt
α=  if [ATP]> σ1 and [NADPH]> θ1 (20) 
] [
[ ] [ ]
5 5 2 2
5 6 2 2
[ ] [ ] [ ]      if [ATP   or  ]
[ ] [ ] [ ]      if   and 
d AcetylCoA pyruv AcetylCoA NADPH
dt
d AcetylCoA pyruv AcetylCoA ATP NADPH
dt
β α σ θ
β α σ θ

= − < <


= − > >

 (21) 
1 1
[ ] [ ] [ ]d citrate AcetylCoA citrate
dt
τ λ= −   (22) 
2 2
[ ] [ ] [ ]d isocitrate citrate isocitrate
dt
τ λ= −   (23) 
3 3
[ ] [ ] [ ]d Ketogl isocitrate Ketogl
dt
α
τ λ α= −   (24) 
4 4
[ ] [ ] [ ]d succinylCoA Ketogl succinylCoA
dt
τ α λ= −  (25) 
5 5
[ ] [ ] [ ]d succinate succinylCoA succinate
dt
τ λ= −   (26) 
6 6
[ ] [ ] [ ]d fumarate succinate fumarate
dt
τ λ= −   (27) 
7 7
[ ] [ ] [ ]d Lmalate fumarate Lmalate
dt
τ λ= −   (28) 
8 8
[ ] [ ] [ ]d ossalacetate Lmalate ossalacetate
dt
τ λ= −  (29) 
6
7
1
[ ] [ . ] [ ][ ]i i
i
d NADH prod NADH NADH ATP
dt
γ α
=
= −∑  (30) 
where 1[ . ] [ ];prod NADH Ketoglα=   2[ . ] [ ];prod NADH fumarate=  3[ . ] [ ];prod NADH AcetylCoA=  
4 1[ . ] [ ];prod NADH pyruv=  5 2[ . ] [ ];prod NADH pyruv=  6[ . ] [ _ _ ]prod NADH A CoA eq=  if [ATP]< σ1 
or [NADPH]> θ1 (Gianni Orsi , personal communication). 
4 6
1 1
[ ] [ . ] [ ] [ . ]i i j
i j
d ATP prod ATP ATP cons ATP
dt
ξ ρ ψ
= =
= −∑ ∑  (31) 
where 1 1[ . ] [ ];prod ATP pyruv=  2 2[ . ] [ ];prod ATP pyruv=  3[ . ] [ ];prod ATP succinate=  
4[ . ] [ ];prod ATP NADH= and 1 8[ . ] [ . .];cons ATP a aα η=  2[ . ] [ 6 ];cons ATP glu P=  
3[ . ] [ ][ ] [ 6 ] / ;cons ATP ATP NADPH d glu P dt=  4[ . ] [ ] / 8;cons ATP AcetylCoA=  
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5[ . ] [ ] /cons ATP d album dt=  if [ATP]< σ3 and [palmitate]> ω0.and 6[ . ] 1cons ATP = for maintenance 
(Gianni Orsi , personal communication).
 
8
[ . .] [ . .]d a a a a
dt
α= −   (32) 
[ ] [ . .]d urea d a a
dt dt
η=   (33) 
6 9
[ _ _ ] [ . .] [ _ _ ]d A CoA eq a a A CoA eq
dt
β α= −   (34) 
7
[ ] [ ]d palmitate AcetylCoA
dt
β=  if [ATP]> σ2 and [NADPH]> θ2 (35) 
2
10
1
[ ] [ . ] [ ]i i
i
d NADPH prod NADPH NADPH
dt
φ α
=
= −∑  (36) 
where 1[ . ] [ _ _ ]prod NADPH A CoA eq=  if [ATP]> σ2 and [NADPH]> θ2 and 
2 2[ . ] [ ]prod NADPH pyruv=  (Gianni Orsi , personal communication). 
8
[ ] [ ] [ ]d album palmitate album
dt
β µ= −  if [ATP]> σ3 and [palmitate]> w0 (37) 
When conditions are not met the differential equations are set to zero. 
The parameters of the model taken from De Maria et al. (2008) are summarized in Table 2. 
 
Table 2. Metabolic HepG2 model parameters, from De Maria et al. (2008). 
Parameter Value Parameter Value Parameter Value Parameter Value 
α1 1/24 β8 1/27 λ8 1.80 ψ4 7.00 
α2 3.01 τ1 1.36 λ9 1.80 ψ5 2330 
α3 2.03 τ2 1.36 γ1 1.00 ψ6 1.00 
α4 1.01 τ3 1.36 γ2 1.00 φ1 6/5 
α5 1.04 τ4 1.47 γ3 1.00 φ2 1.00 
α6 8.31 τ5 1.48 γ4 1.00 µ 1.00 
α7 1.08 τ6 1.48 γ5 0.60 η -0.20 
α8 1/24 τ7 1.76 γ6 1.00 ω
0
 
0.008 
α9 2.11 τ8 1.80 ξ1 3/2 σ1 4.98 
α10 1 λ1 1.36 ξ2 8/5 σ2 5.00 
β2 1.03 λ2 1.36 ξ3 1.00 σ3 4.98 
β3 2.03 λ3 1.47 ξ4 2.50 θ1 1.00 
β4 5/3 λ4 1.48 ρ 0.1 θ2 0.98 
β5 1.04 λ5 1.48 ψ1 3.00   
β6 1.09 λ6 1.76 ψ2 1.00   
β7 1/8 λ7 1.80 ψ3 1.00   
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4.2. Simulated results 
As an example, the model was run for eight days, the initial conditions in ng/(ml.cell) were (Gianni 
Orsi , personal communication): [glu]=3, [a.a.]=2.6, [AcetylCoA] = 0.05, [pyruv1] = 0.05, [pyruv2] = 
0.05, [ATP] = 2.0; [NADH] = 0.05 and at the fourth day the medium was changed and therefore the 
initial concentration of [glu] and [a.a.] were added again to the system. Figures 16-21 show the 
simulated results. 
These results indicate the existence of a dynamic behaviour in the concentrations of the different 
metabolites when performing in vitro experiments. This behaviour should be considered if we are 
interested in assessing toxicity at molecular level. In addition, the change in the medium has a strong 
influence on the dynamics of the metabolism and subsequently on the toxicity effects if the compound 
has a direct or indirect influence on metabolism. 
 
Figure 16.Concentration profiles (ng ml-1cell-1) for [glu], [glu6P] and [pyruvate]=[pyruv1]+[pyruv2]. 
 
The simulated results point out that the initial glucose and amino acids doses disappear practically 
after 4 days, whereas the production of glycogen (carbohydrate biosynthesis), palmitate (fatty acids 
biosynthesis) and albumin (protein biosynthesis) stops before the second day and starts again only after 
the introduction of fresh medium in the system. In addition there are several time scales involved as it 
can be seen in the NADH and ATP dynamics. 
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Figure 17. Concentration profiles (ng ml-1cell-1) for nresidual (Glycogen), [AcetylCoA], [citrate] and 
[isocitrate]. 
 
Figure 18. Concentration profiles (ng ml-1cell-1) for [αKetogl], [succinylCoA], [succinate] and 
[fumarate]. 
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Figure 19. Concentration profiles (ng ml-1cell-1) for [Lmalate], [ossalacetate], [NADH] and [ATP]. 
 
Figure 20. Concentration profiles (ng ml-1cell-1) for [a.a.], [urea], [ACoAeq] and [palmitate]. 
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Figure 21. Concentration profiles (ng ml-1cell-1) for [NADPH] and [albumin]. 
 
Probably the model could be improved by defining continuous sigmoid function for the start/stop of 
several metabolic processes, instead of an on/off switch as it is now implemented. This effect can be 
observed in the flat curves (derivatives set to zero) when some conditions related to [ATP] and 
[NADH] are met. However, it would be first necessary to obtain experimental data to assess the 
validity of the parameters used as well as to develop further the model as a function of measured 
metabolites concentrations. 
4.3. Simulation of toxic effects in the metabolism 
According to Niklas et al. (2009) experimental data, one of the most affected metabolic pathways, in 
absolute value, by the addition of a toxicant is the conversion of pyruvate to acetyl CoA and the 
subsequent Krebs cycle. To simulate this effect we have run several simulations decreasing the rate 
constant β5 which control the pyruvate conversion, see Eq. (21). There is a linear decrease in the 
production of palmitate, whereas a similar behaviour is observed in the albumin, i.e. protein 
biosynthesis, production until β5/250 at which albumin production stops because the concentration of 
palmitate, i.e., fatty acids, drops the threshold value ω0, Eq. (37). 
Other changes observed by Niklas et al. (2009) which involve the fluxes of aminoacids into the cell or 
the DNA and RNA biosynthesis can not be simulated since the metabolic pathways have not been 
included into the model due to the absence of experimental data to develop the kinetic expressions. 
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5. PRELIMINARY CONCLUSIONS AND GENERAL 
RECOMMENDATIONS FOR FUTURE ACTIVITIES 
 
Network analysis provides an alternative approach to link metabolic data, in the form of metabolic 
fluxes, with toxicity data resulting form dose-response experiments. However, this implies that the 
important fluxes (metabolic or not) have been identified and considered in the developed molecular 
model. In our case only the main metabolic fluxes have been considered, but no signaling and 
regulatory fluxes have been considered. Probably, this is the reason why for certain compounds –
amidarone – there are a relationship between several network measurements, e.g. network efficiency, 
and the chemical dose, whereas for other compounds this relationship is not evident – diclofenac –. To 
analyze further this problem, it would be interesting to use chemicals that affect a well-know metabolic 
pathway and to check if in this case more clear correlations emerge.  
The dynamic model results have shown that the metabolic status of a cell line in a cell-based assay 
could be important for the results obtained during a dose-response experiment. For example if a certain 
chemical affects the protein biosynthesis, but this process is slowed due to the consumption of amino 
acids in the medium, this may slow down toxic effects when compared to another experiment where 
amino acids are readily available. For this reason, it would be interesting to check if the dose-response 
curves are affected by the metabolism by changing the starting of time of the experiment, which 
normally is fixed in the experimental procedure. This exercise will provide a way to quantify the 
importance of metabolic activity on the toxic response and provide an explanation for one source of 
variability in cell-based toxicity assays.  
These preliminary results suggest that a combined approach starting from metabolic fluxes obtained 
using experimental data from the metabolomics facility and then, as our experimental data and 
knowledge of metabolic pathways increases, solving the kinetic equations to develop a dynamical 
model of the behaviour of the cell lines, is the most promising avenue to develop to reach a 
quantitative description of toxicity at molecular level. Furthermore, not only metabolic pathways 
should be considered, but it is important to develop an integrated approach combining these networks 
with signalling and regulatory networks (Lee et al., 2008).  
In addition to experimental data necessary to validate and extend the metabolic network pathways, it is 
necessary to link metabolic performance to cellular behaviour in terms of growth and mortality. This is 
necessary to link data at this molecular scale with typical experimental data obtained during cell-based 
assays experiments. Our research is continuing in this direction (Zaldívar et al., 2010). 
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Abstract.  
Chemical toxicity in most of the cases has a metabolic component and metabolic pathways are the 
most studied biochemical reactions. For these reasons we have started to analyze modelling 
approaches for studying toxicity at molecular level using the metabolism and focusing in HepG2 cell 
lines. Two approaches have been investigated. The first consists on the analysis of metabolic fluxes in 
HepG2 under different toxicants concentrations by complex network analysis tools. This is important 
when a correlation between dose-response curves and metabolomic data has to be established. The 
second approach is based on the development and application of a simplified dynamic model of 
metabolism. This approach requires the specification of the biochemical reactions as well as their 
kinetic parameters and, therefore, at the moment, the degree of detail in the description of HepG2 
metabolism is reduced. The results suggest that a combined approach starting from metabolic fluxes 
and then solving the kinetic equations as our experimental data and knowledge of metabolic pathways 
increases is the most promising avenue to develop a quantitative approach of toxicity at molecular 
level. In addition, there is the necessity to link the molecular level approach with the cell growth and 
mortality with an intermediate level that translates metabolism changes into measurable parameters in 
cell-based assays. 
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